| Size | Price | Stock | Qty |
|---|---|---|---|
| 1g |
|
||
| Other Sizes |
| Targets |
1,4-Dibromobenzene-d4 does not have a specific pharmacological target. It is a stable isotope-labeled internal standard used in analytical chemistry, particularly in gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) for the quantification of brominated aromatic compounds. As a deuterated compound, it has no biological activity or pharmacological utility. Its role is strictly analytical, serving as a reference material for accurate quantification.
|
|---|---|
| ln Vitro |
1,4-Dibromobenzene-d4 has no in vitro pharmacological activity. It is an analytical standard and is not used in cell-based assays for biological activity. In vitro studies involving this compound would be limited to analytical method development, such as evaluating extraction efficiency, chromatographic separation, or mass spectrometric detection of brominated compounds. The compound is not intended for biological testing.
|
| ln Vivo |
1,4-Dibromobenzene-d4 has no in vivo pharmacological activity. It is not administered to animals for therapeutic or pharmacological studies. If used in vivo, it would be as a tracer or internal standard in pharmacokinetic studies of brominated compounds, but this is not a typical application. The compound is strictly an analytical reagent and is not used for in vivo studies.
|
| Enzyme Assay |
In vitro enzyme/receptor binding assays are not applicable for 1,4-dibromobenzene-d4, as the compound is not biologically active. It is used exclusively as an analytical standard. If used in biochemical assays, it would serve as a negative control or as a reference for method validation, but it does not interact with enzymes or receptors in a specific manner.
|
| Cell Assay |
In vitro cell-based assays are not applicable for 1,4-dibromobenzene-d4. The compound is not used in cell culture experiments for biological activity assessment. If used in cell-based systems, it would be as a reference compound for analytical method development, not for studying cellular responses. Cytotoxicity assays are not relevant for this compound.
|
| Animal Protocol |
In vivo animal studies are not conducted for 1,4-dibromobenzene-d4 as a test compound. The compound is used as an analytical standard and is not administered to animals for pharmacological or toxicological studies. If used in animal studies, it would be as an internal standard for quantifying brominated compounds in biological samples, but this is not a standard application.
|
| ADME/Pharmacokinetics |
The pharmacokinetic properties of 1,4-dibromobenzene-d4 are not relevant, as the compound is not intended for in vivo administration. As a deuterated analog of 1,4-dibromobenzene, it would be expected to have similar physicochemical properties, including high lipophilicity, low water solubility, and potential for bioaccumulation. However, these properties are not studied for this compound in a pharmacokinetic context.
|
| Toxicity/Toxicokinetics |
The toxicity profile of 1,4-dibromobenzene-d4 has not been systematically evaluated, as it is an analytical standard and not intended for biological exposure. 1,4-Dibromobenzene, the non-deuterated analog, is used as a fumigant and chemical intermediate and can cause dizziness and asphyxiation upon inhalation, and skin or eye contact can cause inflammation and burns. The deuterated compound is expected to have similar toxicity and should be handled with appropriate safety precautions.
|
| References | |
| Additional Infomation |
1,4-Dibromobenzene-d4 is a perdeuterated stable isotope-labeled compound used as a calibration standard for the determination of trace levels of organic compounds. It has the molecular formula C6Br2D4 and a molecular weight of 239.93 g/mol. Applications include analysis of PBDEs, brominated aromatics, and pharmaceutical impurity testing. It is not a therapeutic agent and has no biological activity. The compound is for research use only and is not approved for clinical use.
|
| Molecular Formula |
C6D4BR2
|
|---|---|
| Molecular Weight |
239.93
|
| Exact Mass |
237.893
|
| CAS # |
4165-56-4
|
| PubChem CID |
2733419
|
| Appearance |
White to off-white solid powder
|
| Density |
1.872 g/mL at 25ºC
|
| Boiling Point |
219ºC
|
| Melting Point |
88-90ºC(lit.)
|
| Flash Point |
89.3ºC
|
| Index of Refraction |
1.599
|
| LogP |
3.211
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
0
|
| Rotatable Bond Count |
0
|
| Heavy Atom Count |
8
|
| Complexity |
54.9
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
[2H]C1=C(C(=C(C(=C1Br)[2H])[2H])Br)[2H]
|
| InChi Key |
SWJPEBQEEAHIGZ-RHQRLBAQSA-N
|
| InChi Code |
InChI=1S/C6H4Br2/c7-5-1-2-6(8)4-3-5/h1-4H/i1D,2D,3D,4D
|
| Chemical Name |
1,4-dibromo-2,3,5,6-tetradeuteriobenzene
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.1679 mL | 20.8394 mL | 41.6788 mL | |
| 5 mM | 0.8336 mL | 4.1679 mL | 8.3358 mL | |
| 10 mM | 0.4168 mL | 2.0839 mL | 4.1679 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
